BMS reports positive interim data from Phase III trial of Zeposia
BMS reports data from long-term extension trial of Zeposia. Credit: Sue Adair.
We use cookies to ensure that we give you the best experience on our website. If you continue to use this site we will assume that you are happy with it.ContinueLearn more